Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Operating Income: 2009-2025

Historic Operating Income for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to -$2.0 million.

  • Cumberland Pharmaceuticals' Operating Income fell 15.98% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.3 million, marking a year-over-year increase of 69.70%. This contributed to the annual value of -$6.4 million for FY2024, which is 32.68% up from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Operating Income stood at -$2.0 million for Q3 2025, which was down 162.92% from -$747,478 recorded in Q2 2025.
  • Cumberland Pharmaceuticals' 5-year Operating Income high stood at $1.3 million for Q1 2025, and its period low was -$6.2 million during Q4 2023.
  • Over the past 3 years, Cumberland Pharmaceuticals' median Operating Income value was -$1.7 million (recorded in 2024), while the average stood at -$1.6 million.
  • Per our database at Business Quant, Cumberland Pharmaceuticals' Operating Income plummeted by 4,591.40% in 2024 and then soared by 169.12% in 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Operating Income (Quarterly) stood at -$4.4 million in 2021, then spiked by 47.68% to -$2.3 million in 2022, then slumped by 171.28% to -$6.2 million in 2023, then surged by 70.19% to -$1.8 million in 2024, then declined by 15.98% to -$2.0 million in 2025.
  • Its Operating Income was -$2.0 million in Q3 2025, compared to -$747,478 in Q2 2025 and $1.3 million in Q1 2025.